Dr. Losina's recent webinar, hosted by the Osteoarthritis Action Alliance, is available to view online. Dr. Losina discusses the measurement of physical activity (PA) in those with knee osteoarthritis, as well as the implications of the relatively low levels of PA in this population. Click here to access the webinar.
Click here to read a news feature on a recent OAPol analysis using data from the SPARKS trial. We found that health coaching plus financial incentives may be a cost-effective treatment compared to usual care in total knee replacement recipients.
Bhushan is a former OrACORe research assistant and a current MD candidate at Harvard Medical School (HMS). He spoke with me about his plans and research experiences, before and after OrACORe. ECL: What have you been doing since you left OrACORe? BD: I was a research assistant from January 2014 to July 2016 and then started medical school…
This year, Dr. Katz was selected to receive the Brigham and Women's Physicians Organization Pillar Award for outstanding senior faculty mentor. Dr. Katz was selected based upon his contributions; the support of mentees, peers, and colleagues; and the nomination of Division Chief Dr. James Kang. The Pillar Awards, established in 2013, recognize achievements in five categories viewed as pillars of…
Lindsey MacFarlane, MD, completed a postdoctoral fellowship through OrACORe's COMET T32 training program in 2018. She joins the faculty in Rheumatology at BWH and HMS this spring. ECL: What has been the recent focus of your research, and have you seen it change in the past few years? LM: I’ve always had an interest in OA (osteoarthritis), a common…
NIH Medline Plus discusses the results of the SPARKS trial. Brigham Health's Vital Lines recently featured an OAPol model study examining the lower utilization rates of total knee replacement among racial and ethnic minorities.
Publications Losina E, Usiskin IM, Smith SR, Sullivan JK, Smith KC, Hunter DJ, Messier SP, Paltiel AD, Katz JN. Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: A model-based evaluation. Osteoarthritis Cartilage. 2018 Feb 23. PMID: 29481917. Collins JE. What can our hands tell us about the future of our knees? Arthritis Rheumatol. 2018 Feb 22. PMID: 29471592. Losina E, Katz JN. Hydroxychloroquine: another battle lost in…
An OAPol analysis published last month in Arthritis Care & Research examined the loss of quality-adjusted life years among racial minorities due to disparities in total knee replacement utilization. Click here for coverage by Reuters Health.
ECL: First, can you give us an overview of the TeMPO trial in your own words? Why are we conducting this study? What do we want to know? JS: TeMPO is a randomized controlled trial of treatments for degenerative meniscal tear among adults who also have mild-to-moderate knee osteoarthritis. All the treatments are non-operative, including strengthening exercises and physical therapy…
Dr. Elena Losina was appointed this year as the Robert W. Lovett Professor of Orthopedic Surgery at Harvard Medical School (HMS). Endowed professorships, the highest honor granted to faculty by HMS, recognize researchers, physicians, and professors making outstanding contributions to their fields. Robert W. Lovett was a pioneering orthopedist known in particular for his study of polio. Born in 1859,…